RxDoctor Payments Data

Benjamin Elgamil

Foot & Ankle Surgery · Columbia, MDNPI 1831539303

Payments from drug & device makers

What this record shows

This record is dominated by education: $1,200 of the $1,947 with a category attached, or 61.6%. Supreme Orthopedic Systems, LLC accounts for 62.7% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2022 at $1,391 and has fallen 85.2% since, to $206 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in MD, where the typical reported total is $2,252.

$1,947in general payments, 2019–2025

Across 32 payments — averaging $60.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supreme Orthopedic Systems, LLC$1K
  • Smith+Nephew$231
  • Treace Medical Concepts, Inc.$190
  • Nevro Corp.$60
  • Stryker$48
  • Sebela Pharmaceuticals Inc.$31
  • plus $166 from 9 others

What the payments were for

  • Travel & lodging$50%
  • Food & beverage$74238%
  • Education$1,20062%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,947 in reported general payments places this provider in the 45th percentile of 182 foot & ankle surgery providers in Maryland.

See all foot & ankle surgery providers in Maryland →

Medicare billing

Part B allowed, 2024
$29,462
Medicare patients
121
Services billed
349

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam44$222
Gabapentin14$133
Methylprednisolone13$114

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Columbia

See the full list for Maryland →

Where these figures come from

Is this you, or does something look wrong? →